GRAIL, Inc. (GRAL) stock
GRALNasdaqServices-Medical LaboratoriesFiscal year ends December 31
$115.89−5.46 (-4.50%)
Close on Nov 13, 2026Market cap $5.18BP/E –Yield –
Grail operating margin
Operating margin is operating income as a percentage of revenue.
Grail's operating margin for the twelve months ending Sep 30, 2026 was -347.3%. For fiscal 2025 it was -382.0%, against -1743.0% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -382.0% | +1361.1 |
| FY2024 | Dec 31, 2024 | -1743.0% | −115.4 |
| FY2023 | Dec 31, 2023 | -1627.6% | +8170.6 |
| FY2022 | Jan 1, 2023 | -9798.2% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -385.3% | −39.1 |
| Q2 FY2026 | Jun 30, 2026 | -388.9% | +58.0 |
| Q1 FY2026 | Mar 31, 2026 | -332.9% | +149.6 |
| Q4 FY2025 | Dec 31, 2025 | -285.4% | +72.6 |
| Q3 FY2025 | Sep 30, 2025 | -346.2% | +294.3 |
| Q2 FY2025 | Jun 30, 2025 | -446.9% | +4686.9 |
| Q1 FY2025 | Mar 31, 2025 | -482.5% | +368.6 |
| Q4 FY2024 | Dec 31, 2024 | -358.0% | +283.7 |
| Q3 FY2024 | Sep 30, 2024 | -640.5% | +3762.5 |
| Q2 FY2024 | Jun 30, 2024 | -5133.8% | −4222.1 |
| Q1 FY2024 | Mar 31, 2024 | -851.1% | – |
| Q4 FY2023 | Dec 31, 2023 | -641.7% | – |
| Q3 FY2023 | Oct 1, 2023 | -4403.0% | – |
| Q2 FY2023 | Jun 30, 2023 | -911.8% | – |
See a number that looks wrong?